Cargando…
Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792449/ https://www.ncbi.nlm.nih.gov/pubmed/35083867 http://dx.doi.org/10.1002/ctm2.720 |
| _version_ | 1784640365963247616 |
|---|---|
| author | Zhou, Runhong To, Kelvin Kai‐Wang Peng, Qiaoli Chan, Jacky Man‐Chun Huang, Haode Yang, Dawei Lam, Bosco Hoi‐Shiu Chuang, Vivien Wai‐Man Cai, Jian‐Piao Liu, Na Au, Ka‐Kit Tsang, Owen Tak‐Yin Yuen, Kwok‐Yung Chen, Zhiwei |
| author_facet | Zhou, Runhong To, Kelvin Kai‐Wang Peng, Qiaoli Chan, Jacky Man‐Chun Huang, Haode Yang, Dawei Lam, Bosco Hoi‐Shiu Chuang, Vivien Wai‐Man Cai, Jian‐Piao Liu, Na Au, Ka‐Kit Tsang, Owen Tak‐Yin Yuen, Kwok‐Yung Chen, Zhiwei |
| author_sort | Zhou, Runhong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8792449 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87924492022-02-04 Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses Zhou, Runhong To, Kelvin Kai‐Wang Peng, Qiaoli Chan, Jacky Man‐Chun Huang, Haode Yang, Dawei Lam, Bosco Hoi‐Shiu Chuang, Vivien Wai‐Man Cai, Jian‐Piao Liu, Na Au, Ka‐Kit Tsang, Owen Tak‐Yin Yuen, Kwok‐Yung Chen, Zhiwei Clin Transl Med Letter to Editor John Wiley and Sons Inc. 2022-01-26 /pmc/articles/PMC8792449/ /pubmed/35083867 http://dx.doi.org/10.1002/ctm2.720 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to Editor Zhou, Runhong To, Kelvin Kai‐Wang Peng, Qiaoli Chan, Jacky Man‐Chun Huang, Haode Yang, Dawei Lam, Bosco Hoi‐Shiu Chuang, Vivien Wai‐Man Cai, Jian‐Piao Liu, Na Au, Ka‐Kit Tsang, Owen Tak‐Yin Yuen, Kwok‐Yung Chen, Zhiwei Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses |
| title | Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses |
| title_full | Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses |
| title_fullStr | Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses |
| title_full_unstemmed | Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses |
| title_short | Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses |
| title_sort | vaccine‐breakthrough infection by the sars‐cov‐2 omicron variant elicits broadly cross‐reactive immune responses |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792449/ https://www.ncbi.nlm.nih.gov/pubmed/35083867 http://dx.doi.org/10.1002/ctm2.720 |
| work_keys_str_mv | AT zhourunhong vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT tokelvinkaiwang vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT pengqiaoli vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT chanjackymanchun vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT huanghaode vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT yangdawei vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT lamboscohoishiu vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT chuangvivienwaiman vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT caijianpiao vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT liuna vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT aukakit vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT tsangowentakyin vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT yuenkwokyung vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses AT chenzhiwei vaccinebreakthroughinfectionbythesarscov2omicronvariantelicitsbroadlycrossreactiveimmuneresponses |